Journal article
Prevalence of awareness, ever-use and current use of nicotine vaping products (NVPs) among adult current smokers and ex-smokers in 14 countries with differing regulations on sales and marketing of NVPs: cross-sectional findings from the ITC Project
Shannon Gravely, Pete Driezen, Janine Ouimet, Anne CK Quah, K Michael Cummings, Mary E Thompson, Christian Boudreau, David Hammond, Ann McNeill, Ron Borland, James F Thrasher, Richard Edwards, Maizurah Omar, Sara C Hitchman, Hua-Hie Yong, Tonatiuh Barrientos-Gutierrez, Marc C Willemsen, Eduardo Bianco, Marcelo Boado, Fastone Mathew Goma Show all
Addiction | WILEY | Published : 2019
DOI: 10.1111/add.14558
Abstract
AIMS: This paper presents updated prevalence estimates of awareness, ever-use, and current use of nicotine vaping products (NVPs) from 14 International Tobacco Control Policy Evaluation Project (ITC Project) countries that have varying regulations governing NVP sales and marketing. DESIGN, SETTING, PARTICIPANTS AND MEASUREMENTS: A cross-sectional analysis of adult (≥ 18 years) current smokers and ex-smokers from 14 countries participating in the ITC Project. Data from the most recent survey questionnaire for each country were included, which spanned the period 2013-17. Countries were categorized into four groups based on regulations governing NVP sales and marketing (allowable or not), and l..
View full abstract
Grants
Awarded by US National Cancer Institute
Awarded by Canadian Institutes of Health Research
Awarded by National Health and Medical Research Council of Australia
Awarded by Dutch Cancer Foundation (KWF)
Awarded by Brazil Fundacao do Cancer
Awarded by Health Research Council of New Zealand
Awarded by Mexican Consejo Nacional de Ciencia y Tecnologia
Awarded by Canadian Cancer Society (CCS) Career Development Award in Cancer Prevention
Funding Acknowledgements
The ITC country data in this paper were supported by grants from the US National Cancer Institute (P01CA138389, P01CA200512, R01 TW010652), the Canadian Institutes of Health Research (MOP 115016, FDN 148477), the National Health and Medical Research Council of Australia (APP1106451), the Korean Ministry of Health and Welfare, the Dutch Cancer Foundation (KWF) (UM 2014-7210), the National Cancer Institute of Brazil (INCA), Pan-American Health Organization (PAHO), Brazil Fundacao do Cancer (BR/LOA/1500048.001), the Chinese Centre for Disease Control and Prevention, the Health Research Council of New Zealand (GA215F 15/072), the New Zealand Ministry of Health and the Mexican Consejo Nacional de Ciencia y Tecnologia (Salud-2007-C01-70032 and Salud-2013-01-202671). S.G. was supported by a Canadian Cancer Society (CCS) Career Development Award in Cancer Prevention (no. 703858). G.T.F. was supported by a Senior Investigator Award from the Ontario Institute for Cancer Research and a Prevention Scientist Award from the Canadian Cancer Society Research Institute. The authors would also like to gratefully acknowledge the reviewers for their insightful comments and suggestions which served to strengthen this paper.